Diane Parks
Director/Board Member at CALLIDITAS THERAPEUTICS AB
Net worth: 96 199 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Troy Wilson | M | 55 | 10 years | |
| Mary Szela | F | 60 |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | 6 years |
| Adam Craig | M | 58 | 7 years | |
| Robert Hariri Gordon | M | 65 | 8 years | |
| Christopher Schaber | M | 57 | 18 years | |
| Hilde Furberg | F | 65 | 10 years | |
| Laurent Fischer | M | 60 | 7 years | |
| Jonathan Guarino | M | 51 | 5 years | |
| Reed Tuckson | M | 73 | 13 years | |
| Jim Fong | M | 62 | 16 years | |
| Tyler Jacks | M | 63 | 12 years | |
| Greg Garland | M | 66 | 11 years | |
| Margareta Elisabeth Björk | M | 63 | 2 years | |
| Esteban Santos | M | 56 | 17 years | |
| Helen Collins | M | 62 | 3 years | |
| Teresa Bair | F | 53 | 3 years | |
| John Haines | M | 66 | - | |
| John Volpone | M | - | - | |
| Thomas Doyle | M | 53 | 3 years | |
| Wulff-Erik von Borcke | M | - | 9 years | |
| Jerome Zeldis | M | 74 | 13 years | |
| Pete de Spain | M | - | 7 years | |
| Thomas Malley | M | 55 | 9 years | |
| Carol Schafer | F | 60 | 3 years | |
| Gregg Lapointe | M | 65 | 15 years | |
| Faheem Hasnain | M | 65 | 9 years | |
| Marc Mazur | M | 64 | 3 years | |
| Peter Diamandis | M | 62 | 7 years | |
| Dean Kehler | M | 67 | 6 years | |
| Robert Rubin | M | 78 | 15 years | |
| Ronald Sugar | M | 75 | 14 years | |
| K Fletcher | M | - | - | |
| Henrik Stenqvist | M | 57 | 2 years | |
| Johan Erik Häggblad | M | 65 | 17 years | |
| David Kirske | M | 69 | 7 years | |
| David Parkinson | M | 73 | 7 years | |
| Elmar Schnee | M | 65 | 5 years | |
| Randy Gascoyne | M | - |
Lymphoma Research Foundation
| - |
| Max Mulcahy | M | - |
Lymphoma Research Foundation
| - |
| Peggy Torney | F | - |
Lymphoma Research Foundation
| - |
| Nathan Fowler | M | - |
Lymphoma Research Foundation
| - |
| Donna Reinbolt | F | - |
Lymphoma Research Foundation
| - |
| Kristie Blum | F | - |
Lymphoma Research Foundation
| - |
| Laura Pasqualucci | F | - |
Lymphoma Research Foundation
| - |
| Tim Wilk | M | - | - | |
| Beth Steinbrenner | F | - | 7 years | |
| Thomas Witzig | M | - |
Lymphoma Research Foundation
| - |
| Steven Eichberg | M | - |
Lymphoma Research Foundation
| - |
| Taylor Kahn | F | - |
Lymphoma Research Foundation
| - |
| Gene R. McGrevin | M | 81 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | 12 years |
| Stephen Ansell | M | - |
Lymphoma Research Foundation
| - |
| Neil Kay | M | - |
Lymphoma Research Foundation
| - |
| Ann LaCasce | F | - |
Lymphoma Research Foundation
| - |
| Jonathan Friedberg | M | - |
Lymphoma Research Foundation
| - |
| Anas Younes | M | - |
Lymphoma Research Foundation
| - |
| Andrew Zelenetz | M | - |
Lymphoma Research Foundation
| - |
| Jerry Freundlich | M | - |
Lymphoma Research Foundation
| - |
| Craig Moskowitz | M | - |
Lymphoma Research Foundation
| - |
| Kathleen Ford | F | 77 | 5 years | |
| Simone Song | F | 59 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | - |
| John L. Tullis | M | - |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | - |
| Mats Wahlström | M | 70 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | 7 years |
| Kerry Hicks | M | 64 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | - |
| John Colerangle | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bruce J. Seeley | M | 59 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Ian Clark | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 14 years |
| Ramses Erdtmann | M | 60 | 6 years | |
| Robert Duggan | M | 79 | 7 years | |
| Arie Belldegrun | M | 74 | 8 years | |
| Marc M. P. de Garidel | M | 66 | 15 years | |
| Bradley Glover | M | 55 | 2 years | |
| James Basta | M | 58 | - | |
| Robert A. Swanson | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| David Chang | M | 64 | 12 years | |
| Shawn Tomasello | F | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 21 years |
| Manmeet Singh Soni | M | 46 | 3 years | |
| Jonathan Peacock | M | 66 | 7 years | |
| David Tanen | M | 52 | - | |
| Marc Grasso | M | 51 | 4 years | |
| Timothy Moore | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 3 years |
| Mahkam Zanganeh | M | 52 | 7 years | |
| Kevin Sharer | M | 76 | 20 years | |
| Louis Lavigne | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Dennis Fenton | M | 72 | 27 years | |
| David W. Beier | M | 75 | 10 years | |
| Pamela Wapnick | F | 58 | 9 years | |
| Karen R. Krumeich | F | 70 | 3 years | |
| Bengt Åke Julander | M | 71 | 16 years | |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Craig Shepherd | M | - | 7 years | |
| John Moriarty | M | 56 | 6 years | |
| Thomas Johannes W. Dittrich | M | 60 | 4 years | |
| Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Annette L. Such | F | 55 | - | |
| Ryan Watts | M | 48 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Robert Azelby | M | 56 | 5 years | |
| Joseph Newell | M | 54 | 7 years | |
| Rachel Lenington | F | 51 | 10 years | |
| Christine Cassiano | F | - | 1 years | |
| Thomas Zindrick | M | 65 | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 94.00% |
| Sweden | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Diane Parks
- Personal Network